Day: 4 July 2024

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Tokyo key stocks close at all-time highs

Tokyo stocks climbed Thursday, with their broader index ending at a 34-year, following overnight gains on Wall Street.

The Tokyo Stock Price Index, which includes all shares of the First Section on the Tokyo Stock Exchange, advanced 26.29 points, or …

Kuwait oil price down to USD 88.46 pb

The price of Kuwaiti oil went down 43 cents to reach USD 88.46 per barrel on Wednesday as opposed to USD 88.89 last Tuesday, said the Kuwait Petroleum Corporation (KPC) on Thursday.

On a global scale, the price of the Brent crude futures’ contracts w…